Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Poor quality product administered, Product temperature excursion issue
Clinical narrative: Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021 at 11:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 21-Mar-2021 at 11:25 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 14-Feb-2021 at 11:30 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 36.00 on 14-Feb-2021 and 36.10 on 21-Mar-2021.  Concomitant medication information was not provided by the reporter.  Vial was moved to clinic on 13-Jan-2021. Vaccine was moved to fridge on 09-Feb-2021. On 14-Feb-2021, Excursion time was 09 AM, 10 AM and 11 AM, temperature was 32 respectively, Excursion time was 02 PM and 03 PM, temperature was 35 respectively, total doses given for the day was 162, condition of vaccine prior to administration was not frozen. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021 (Batch: 031L20A).  Vaccine was moved to fridge on 16-Mar-2021. Vial was moved to clinic on 21-Mar-2021. On 21-Mar-2021, Excursion time was 09 AM, temperature was 34, excursion time was 10 AM, temperature was 32, excursion time was 11 AM, temperature was 34, total doses given for the day was 94, condition of vaccine prior to administration was not frozen. 10 vials were sent to clinic. Vaccine BUD date was 15-Apr-2021. (Batch: 003B21A)  On 21-Mar-2021, vials were stored in cooler 1, following are the time and temperature respectively, 9 AM: 34, 10 AM: 32, 11 AM: 34, 12 PM: 43, 1PM: 40, 2 PM: 40, 3 PM: 41, 4 PM: 41 and 5 PM: 41.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment information was not provided by the reporter.   This case was linked to MOD-2022-566976 (Patient Link).